21 June 2013

Scientists investigate how aspirin may fight cancer

Aspirin and related drugs may fight cancer by lowering rates of DNA mutation, a new study suggests.

Aspirin and related drugs may fight cancer by lowering rates of DNA mutation, a small new study suggests.

It's known that aspirin reduces the risk for some cancers, and these findings point to a possible explanation, according to the researchers from the University of California, San Francisco.

They analyzed tissue samples from 13 patients with a condition called Barrett's oesophagus, which can lead to oesophageal cancer. The patients were followed for between six and 19 years. Patients took aspirin at different times during the study.

Mutations in tissue samples collected while patients were on aspirin had accumulated an average of 10 times more slowly than in samples obtained when patients were not taking aspirin, according to the study, which was published online June 13 in the journal PLoS Genetics. The study did not, however, prove a cause-and-effect link between aspirin and slower rates of gene mutations.

Lower mutation rates

"Aspirin and other non-steroidal anti-inflammatory drugs, which are commonly available and cost-effective medications, may exert cancer-preventing effects by lowering mutation rates," researcher Carlo Maley, a member of the UCSF Helen Diller Family Comprehensive Cancer Center, said in a university news release.

"This is the first study to measure genome-wide mutation rates of a pre-malignant tissue within patients for more than a decade, and the first to evaluate how aspirin affects those rates," he added.

Maley said aspirin may lower DNA mutation rates by reducing inflammation, and plans to further investigate this theory.

More information

The US National Cancer Institute has more about cancer prevention.


Read Health24’s Comments Policy

Comment on this story
Comments have been closed for this article.

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst. For more information, visit

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules